Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-043289

President & CEO sold 100,000 shares at an average $31.29 ($3,128,667)

  • President & CEO acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2019-07-23 Option exercise +33,333 $7.21 $240,331 328,659 D: show line 1 in the form
ROBIN HOWARD W President & CEO 2019-07-23 Sale −33,333 $32.10 $1,069,989 295,326 D: show line 2 in the form
ROBIN HOWARD W President & CEO 2019-07-24 Option exercise +33,334 $7.21 $240,338 328,660 D: show line 3 in the form
ROBIN HOWARD W President & CEO 2019-07-24 Sale −33,334 $32.11 $1,070,355 295,326 D: show line 4 in the form
ROBIN HOWARD W President & CEO 2019-07-25 Option exercise +33,333 $7.21 $240,331 328,659 D: show line 5 in the form
ROBIN HOWARD W President & CEO 2019-07-25 Sale −33,333 $29.65 $988,323 295,326 D: show line 6 in the form
Open-market sales · 100,000 sh · avg $31.29 · $3,128,667

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2019-07-23 Option exercise · Common Stock −33,333 166,667 D: show line 7 in the form
ROBIN HOWARD W President & CEO 2019-07-24 Option exercise · Common Stock −33,334 132,333 D: show line 8 in the form
ROBIN HOWARD W President & CEO 2019-07-25 Option exercise · Common Stock −33,333 100,000 D: show line 9 in the form
Loading xslF345X03/doc4.xml…